Zepp Health (NYSE:ZEPP) PT Set at $14.65 by Fundamental Research

Zepp Health (NYSE:ZEPP) received a $14.65 price objective from research analysts at Fundamental Research in a research note issued to investors on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Fundamental Research’s price target suggests a potential upside of 432.73% from the stock’s current price.

Zepp Health Stock Down 7.1 %

ZEPP stock opened at $2.75 on Tuesday. The company’s 50 day moving average price is $3.35 and its 200 day moving average price is $2.99. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.87 and a current ratio of 1.21. Zepp Health has a fifty-two week low of $2.06 and a fifty-two week high of $8.40. The firm has a market capitalization of $41.39 million, a price-to-earnings ratio of -1.10 and a beta of 0.68.

Institutional Trading of Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC purchased a new stake in Zepp Health Co. (NYSE:ZEPP) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned about 0.09% of Zepp Health as of its most recent SEC filing. 52.61% of the stock is currently owned by institutional investors.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.